Ezetimibe in the Treatment of Uncontrolled Hyperlipidemia in Kidney Transplant Patients

Transplantation Proceedings

Volumn 40, Issue 10, 2008, Pages 3492-3495

  Rodriguez Ferrero M L ^a   Anaya, F ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; ATORVASTATIN; AZATHIOPRINE; CHOLESTEROL; CREATINE KINASE; CYCLOSPORIN A; EVEROLIMUS; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PRAVASTATIN; PREDNISOLONE; SIMVASTATIN; TACROLIMUS; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER FUNCTION; MALE; MYALGIA; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHOLESTEROL; CHOLESTEROL, LDL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERLIPIDEMIAS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIPIDS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; REOPERATION; TRIGLYCERIDES;

EID: 57549114261     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.04.018     Document Type: Article

References (17)

1. Bumgardner G.L., and Wilson G.A. Impact of serum lipids on long-term graft and patient survival after renal transplantation. Transplantation 60 (1995) 1418
2. Kobashigawa J.A., and Kasiske B.I. Hyperlipidemia in solid organ transplantation. Transplantation 63 (1997) 331
3. Kanbay M., Yildirir A., Akcay A., et al. Effects of immunosuppressive drugs on serum lipid levels in renal transplant recipients. Transplant Proc 38 (2006) 502
4. Briggs J.D. Causes of death after renal transplantation. Nephrol Dial Transplant 16 (2001) 1545
5. Renders L., Mayer-Kadner I., Koch C., et al. Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients. Nephrol Dial Transplant 16 (2001) 141
6. Kosoglou T., Statkevich P., and Johnson-Levonas A.O. Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet 44 (2005) 467
7. Toth P.P., and Davidson M.H. Cholesterol absorption blockade with ezetimibe. Curr Drug Targets Cardiovasc Haematol Disord 5 (2005) 455
8. Altmann S.W. Niemann-Pick Cl-Like 1 protein is critical for intestinal cholesterol absorption. Science 303 (2004) 1201
9. Ballantyne C.M., Houri J., Notarbartolo A., et al. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Circulation 107 (2003) 2409
10. Puthenparumpil J.J., Keough-Ryan T., Kiberd M., et al. Treatment of hypercholesterolemia with ezetimibe in the kidney transplant populations. Transplant Proc 37 (2005) 1033
11. Langone A.J., and Chuang P. Ezetimibe in renal transplant patients with hyperlipidemia resistant to HMG-CoA reductase inhibitors. Transplantation 81 (2006) 804
12. Buchanan C., Smith L., Corbett J., et al. A retrospective analysis of ezetimibe treatment in renal transplant recipients. Am J Transplant 6 (2006) 770
13. Kohnle M., Pietruck F., Kribben A., et al. Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation. Am J Transplant 6 (2006) 205
14. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Kidney Transplant Patients. Am J Transplant 4 Suppl 7 (2004) 13
15. Page U., Gerhardt T., and Palmedo H. MDRD equations for estimation of GFR in renal transplant recipients. Am J Transplant 5 (2005) 1306
16. Chuang P., and Langone A.J. Ezetimibe reduces low-density lipoprotein cholesterol (LDL-C) in renal transplant patients resistant to HMG-CoA reductase inhibitors. Am J Ther 14 (2007) 438
17. Koshman S.L., Lalonde L.D., Burton I., et al. Supratherapeutic response to ezetimibe administered with cyclosporine. Ann Pharmacother 39 (2005) 432